FDA Requires Boxed Warning on Lidocaine Viscous – Not to Be Used to Treat Teething Pain: AttorneyOne

On June 26, the FDA informed that prescription oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. (PRWEB) July 03, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for Lidocaine Viscous. The FDA issued a safety communication on June 26, stating that prescription oral viscous lidocaine 2% solution should not be u
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations